ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,750.00
-230.00 (-5.78%)
At close: Aug 7, 2025, 3:30 PM KST
-5.78%
Market Cap47.23B
Revenue (ttm)11.66B
Net Income (ttm)-4.07B
Shares Out12.59M
EPS (ttm)-440.11
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume260,658
Average Volume1,029,682
Open3,960.00
Previous Close3,980.00
Day's Range3,710.00 - 3,960.00
52-Week Range1,351.00 - 5,450.00
Beta1.34
RSI59.42
Earnings DateAug 11, 2025

About Verve Therapeutics

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 59
Stock Exchange KOSDAQ
Ticker Symbol 179530
Full Company Profile

Financial Performance

In 2024, ADBiotech's revenue was 11.14 billion, an increase of 6.34% compared to the previous year's 10.47 billion. Losses were -7.95 billion, 177.7% more than in 2023.

Financial Statements

News

There is no news available yet.